Literature DB >> 28733910

A review study to evaluate holmium:YAG laser lithotripsy with flexible ureteroscopy in patients on ongoing oral anticoagulant therapy.

Bulent Altay1, Bulent Erkurt2, Selami Albayrak2.   

Abstract

The objective of this study was to evaluate the safety and efficacy of flexible ureteroscopy (FURS) and holmium:YAG laser lithotripsy for the treatment of upper urinary tract stones in patients on active oral anticoagulants. The records of 1081 patients who underwent flexible ureteroscopic holmium:YAG (Ho:YAG) laser lithotripsy for upper ureteral and renal calculi from 1999 to 2015 were retrospectively reviewed. A total of 84 patients on continuous oral anticoagulation or antiplatelet therapy (warfarin, aspirin, or clopidogrel) were identified. Of these patients, 40 were on warfarin, 25 on aspirin, 11 on clopidogrel, and 8 on both aspirin and clopidogrel. The drugs were not discontinued. The baseline characteristics, indications for anticoagulation therapy, perioperative data, stone-free rate, and complications were documented. Evaluation of outcomes was assessed at 1-, 3-, and 6-month follow-up postoperatively. Mean stone size was 19.7 ± 9.4 (range 8 to 31 mm). Twenty patients had upper ureteral and 64 patients had intrarenal calculi. Two patients had bilateral renal calculi. Mean operation time was 78.2 ± 23.8 min (range 17 to 144 min). Two procedures (2.3%) in warfarin group were terminated due to persistent bleeding causing visual impairment. No transfusions were required. The mean serum hemoglobin levels did not change significantly (12.9 ± 3.7 to 12.2 ± 3.3 g/dL). No thromboembolic or cardiac adverse events were observed perioperatively. The double-j (DJ) ureteral catheterization time was 29.6 ± 9.3 days (range 14 to 68 days) and the hospital stay was 1.6 ± 0.6 days (range 1 to 4). The stone-free rate was 95.2% (80 patients) at 6 months. Flexible ureteroscopic Ho:YAG laser lithotripsy in patients requiring long-term anticoagulation therapy seems to be a safe and effective procedure and should be considered as a first-line treatment option in such patients for the surgical management of upper urinary tract stones.

Entities:  

Keywords:  Flexible ureteroscopy; Ho:YAG laser; Kidney stone; Oral anticoagulants

Mesh:

Substances:

Year:  2017        PMID: 28733910     DOI: 10.1007/s10103-017-2289-4

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  19 in total

1.  CUA Guideline: Management of ureteral calculi.

Authors:  Michael Ordon; Sero Andonian; Brian Blew; Trevor Schuler; Ben Chew; Kenneth T Pace
Journal:  Can Urol Assoc J       Date:  2015-12-14       Impact factor: 1.862

Review 2.  Antiplatelet drugs.

Authors:  Gustav Born; Carlo Patrono
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 3.  Holmium laser for stone management.

Authors:  Sean Pierre; Glenn M Preminger
Journal:  World J Urol       Date:  2007-03-06       Impact factor: 4.226

Review 4.  The holmium laser in urology.

Authors:  T A Wollin; J D Denstedt
Journal:  J Clin Laser Med Surg       Date:  1998-02

5.  Intracorporeal lithotripsy with the holmium:YAG laser.

Authors:  H A Razvi; J D Denstedt; S S Chun; J L Sales
Journal:  J Urol       Date:  1996-09       Impact factor: 7.450

6.  Missed opportunities for prevention of venous thromboembolism: an evaluation of the use of thromboprophylaxis guidelines.

Authors:  D M Arnold; S R Kahn; I Shrier
Journal:  Chest       Date:  2001-12       Impact factor: 9.410

7.  Extracorporeal shockwave lithotripsy in patients treated with antithrombotic agents.

Authors:  G Zanetti; I Kartalas-Goumas; E Montanari; A B Federici; A Trinchieri; F Rovera; E Pisani
Journal:  J Endourol       Date:  2001-04       Impact factor: 2.942

Review 8.  Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments.

Authors:  Jessica L Mega; Tabassome Simon
Journal:  Lancet       Date:  2015-03-14       Impact factor: 79.321

9.  A comparison of the FREDDY and holmium lasers during ureteroscopic lithotripsy.

Authors:  Jennifer Yates; August Zabbo; Gyan Pareek
Journal:  Lasers Surg Med       Date:  2007-09       Impact factor: 4.025

10.  Use of ureteroscopy and holmium:YAG laser in patients with bleeding diatheses.

Authors:  R L Kuo; P Aslan; K B Fitzgerald; G M Preminger
Journal:  Urology       Date:  1998-10       Impact factor: 2.649

View more
  3 in total

1.  Holmium:yttrium-aluminum-garnet laser induced lithotripsy: in-vitro investigations on fragmentation, dusting, propulsion and fluorescence.

Authors:  Maximilian Eisel; Stephan Ströbl; Thomas Pongratz; Frank Strittmatter; Ronald Sroka
Journal:  Biomed Opt Express       Date:  2018-10-02       Impact factor: 3.732

2.  Multiple renal ruptures after flexible ureteroscopic lithotripsy with holmium laser.

Authors:  Xianghu Meng; Rong Cong; Rijin Song; Pei Lu; Wei Zhang; Zengjun Wang
Journal:  AME Case Rep       Date:  2020-01-20

Review 3.  Advances in Lasers for the Treatment of Stones-a Systematic Review.

Authors:  Peter Kronenberg; Bhaskar Somani
Journal:  Curr Urol Rep       Date:  2018-05-17       Impact factor: 3.092

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.